Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2019-10-01 Director's Dealing
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Indberetning af ledende medarbejders og disses nærtståendes transaktioner
Director's Dealing Classification · 100% confidence The document is a standard regulatory form used in Denmark (Finanstilsynet) for reporting transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons. It details specific share transactions (acquisition of unlisted B-shares) by Erhvervsinvest ApS, which is linked to the CEO and a board member of Blue Vision A/S. This falls under the category of Director's Dealing (DIRS).
2019-10-01 Danish
Indberetning af ledende medarbejders og disses nærtståendes transaktioner
Director's Dealing Classification · 100% confidence The document is a short announcement (Selskabsmeddelelse nr. 16) from Blue Vision A/S regarding the notification of transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons, as required by the EU Market Abuse Regulation (MAR). While the content relates to director/insider dealings, the document itself serves as a formal notification/announcement of these transactions, which fits the 'Director's Dealing' (DIRS) category.
2019-10-01 English
Director's Dealing 2019
Director's Dealing Classification · 100% confidence The document text is structured as a template or form detailing how transactions executed by persons discharging managerial responsibilities (PDMRs) and their closely associated persons must be reported and made public. The headings explicitly mention 'personer med ledelsesansvar' (persons with managerial responsibilities), 'transaktioner' (transactions), 'pris(er) og mængde(r)' (price(s) and quantity(ies)), and 'dato for transaktionen' (date of the transaction). This structure is characteristic of insider trading reports or director's dealing disclosures, which track share transactions by company insiders. Based on the provided definitions, 'Director's Dealing (Code: DIRS)' is the most appropriate classification for reports detailing personal share transactions by company directors and executives.
2019-10-01 Danish
Ledelsesændring med ny administrerende direktør
Board/Management Information Classification · 99% confidence The document is a short corporate announcement (Selskabsmeddelelse nr.: 15) detailing the appointment of a new CEO (Peter Hauge Jensen) and changes in the management structure, with quotes from the Chairman and the new CEO. This directly corresponds to the definition of Board/Management Information, which is classified as 'MANG'. The document length is very short (1870 chars), but its content is the primary announcement itself, not an announcement *about* a report, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule for this specific content type.
2019-09-30 Danish
Board/Management Information 2019
Board/Management Information Classification · 100% confidence The document is titled "Ledelsesændring med ny administrerende direktør" (Management Change with new CEO) and explicitly announces the hiring of Peter Hauge Jensen as the new CEO for Blue Vision A/S, including quotes from the Chairman and the new CEO regarding the transition. This content directly corresponds to the definition of Board/Management Information.
2019-09-30 Danish
Ledelsesændring med ny administrerende direktør
Board/Management Information Classification · 99% confidence The document is a short announcement (Selskabsmeddelelse nr.: 15) detailing the appointment of a new CEO (Peter Hauge Jensen) and changes in the management structure, with quotes from the Chairman (Nicolai Kærgaard). This content directly relates to changes in senior management personnel. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category.
2019-09-30 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.